---
title: "Mosaic BRAF fusions are a recurrent cause of congenital melanocytic naevi targetable by MEK inhibition"
collection: publications
permalink: /publication/2023-09-18-PAPER-JID-GeneFusions
excerpt: 'This paper reports mosaic BRAF and RAF fusions as a cause of CMN.'
date: 2023-09-18
venue: 'The Journal of Investigative Dermatology'
paperurl: 'https://doi.org/10.1016/j.jid.2023.06.213'
citation: 'Martin SB#, Polubothu S#, Bruzos AL# et al. (2023). &quot;Mosaic BRAF fusions are a recurrent cause of congenital melanocytic naevi targetable by MEK inhibition.&quot; <i>The Journal of Investigative Dermatology</i>. doi: 10.1016/j.jid.2023.06.213 - IF(2021) = 7.590 (#equal contribution)'
---

**Alicia's citation:**  
Martin SB#, Polubothu S#, Bruzos AL# et al. 2023. "Mosaic BRAF fusions are a recurrent cause of congenital melanocytic naevi targetable by MEK inhibition." <i>The Journal of Investigative Dermatology</i>, doi: 10.1016/j.jid.2023.06.213 (#equal contribution). IF(2021) = 7.590.  

**All authors citation:**  
Martin SB#, Polubothu S#, Bruzos AL#, Kelly G, Horswell S, Sauvadet A, Bryant D, Zecchin D, Riachi M, Michailidis F, Sadri A, Muwanga-Nanyonjo N, Lopez-Balboa P, Knöpfel N, Bulstrode N, Pittman A, Yeh I, Kinsler V, Mosaic BRAF fusions are a recurrent cause of congenital melanocytic naevi targetable by MEK inhibition, The Journal of Investigative Dermatology (2023), DOI: [10.1016/j.jid.2023.06.213](https://doi.org/10.1016/j.jid.2023.06.213) IF(2021) = 7.590 (#equal contribution)


**Authorship:**  
Position of AL Bruzos: 3  
Total number of authors: 18  
Authors: Sara Barberan Martin; Satyamaanasa Polubothu; Alicia Lopez Bruzos; Gavin Kelly; Stuart Horswell; Aimie Sauvadet; Dale Bryant; Davide Zecchin; Melissa Riachi; Fanourios Michailidis; Amir Sadri; Noreen Muwanga-Nanyonjo; Pablo Lopez-Balboa; Nicole Knöpfel; Neil Bulstrode; Alan Pittman; Iwei Yeh; Veronica Kinsler

**Journal information**  
ISSN: 0022-202X  
eISSN: 1523-1747      
Current Publisher:  *ELSEVIER SCIENCE INC*, STE 800, 230 PARK AVE, NEW YORK, USA, NY, 10169   
  
*Journal Impact Factor (JIF)*  
-JIF: 7.590 (2021)  
-JIF Rank: 5/68 (2021 - pending to update)  
-JIF Quartile: Q1 (2021 - pending to update)   
*Journal Citation Indicator (JCI)*  
-JCR Category: DERMATOLOGY  
-JCR Category Rank: -    
-JCR Category Quartile: -    

**Peer-review process:**  
Received: 1 February 2023  
Accepted: 16 May 2023  
Published: 18 September 2023
